113 related articles for article (PubMed ID: 16112045)
1. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
[TBL] [Abstract][Full Text] [Related]
2. Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis.
Gertz MA; Lacy MQ; Dispenzieri A; Buadi FK; Dingli D; Hayman SR; Kumar SK; Leung N; Lust J; Rajkumar SV; Russell SJ; Suman VJ; Le-Rademacher JG; Hogan WJ
Cancer; 2016 Jul; 122(14):2197-205. PubMed ID: 27142462
[TBL] [Abstract][Full Text] [Related]
3. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
D'Souza A; Dispenzieri A; Wirk B; Zhang MJ; Huang J; Gertz MA; Kyle RA; Kumar S; Comenzo RL; Peter Gale R; Lazarus HM; Savani BN; Cornell RF; Weiss BM; Vogl DT; Freytes CO; Scott EC; Landau HJ; Moreb JS; Costa LJ; Ramanathan M; Callander NS; Kamble RT; Olsson RF; Ganguly S; Nishihori T; Kindwall-Keller TL; Wood WA; Mark TM; Hari P
J Clin Oncol; 2015 Nov; 33(32):3741-9. PubMed ID: 26371138
[TBL] [Abstract][Full Text] [Related]
4. New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation.
D'Souza A; Huang J; Hari P
Biol Blood Marrow Transplant; 2016 Apr; 22(4):768-770. PubMed ID: 26743343
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Afrough A; Saliba RM; Hamdi A; El Fakih R; Varma A; Dinh YT; Rondon G; Cornelison AM; Shah ND; Bashir Q; Shah JJ; Hosing C; Popat U; Orlowski RZ; Champlin RE; Parmar S; Qazilbash MH
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1413-7. PubMed ID: 25842049
[TBL] [Abstract][Full Text] [Related]
6. High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
Varga C; Comenzo RL
Bone Marrow Transplant; 2019 Apr; 54(4):508-518. PubMed ID: 30089901
[TBL] [Abstract][Full Text] [Related]
7. Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Pianko MJ; Tiutan T; Derkach A; Flynn J; Salvatore SP; Jaffer-Sathick I; Rossi AC; Lahoud O; Hultcrantz M; Shah UA; Maclachlan K; Chung DJ; Shah GL; Landau HJ; Korde N; Mailankody S; Lesokhin AM; Tan C; Scordo M; Jaimes EA; Giralt SA; Usmani S; Hassoun H
Am J Hematol; 2023 Mar; 98(3):421-431. PubMed ID: 36588413
[TBL] [Abstract][Full Text] [Related]
8. Novel Therapies in Light Chain Amyloidosis.
Milani P; Merlini G; Palladini G
Kidney Int Rep; 2018 May; 3(3):530-541. PubMed ID: 29854961
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury during autologous stem cell transplantation in light chain amyloidosis with kidney involvement and their impact on prognosis.
Xu W; Chen W; Guo J; Zhao L; Ren G; Huang X
Bone Marrow Transplant; 2024 Apr; ():. PubMed ID: 38658659
[TBL] [Abstract][Full Text] [Related]
10. Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation.
González-López TJ; Vázquez L; Flores T; San Miguel JF; García-Sanz R
Clin Pract; 2011 Sep; 1(4):e95. PubMed ID: 24765395
[TBL] [Abstract][Full Text] [Related]
11. Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.
Lousada I; Comenzo RL; Landau H; Guthrie S; Merlini G
Adv Ther; 2015 Oct; 32(10):920-8. PubMed ID: 26498944
[TBL] [Abstract][Full Text] [Related]
12. High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy.
Mellgard GS; Bhutani D; Mapara MY; Maurer MS; Radhakrishnan J; Lentzsch S; Chakraborty R
Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38724598
[No Abstract] [Full Text] [Related]
13. Systemic Amyloidosis and Kidney Transplantation: An Update.
Anand SK; Sanchorawala V; Verma A
Semin Nephrol; 2024 Mar; ():151496. PubMed ID: 38490903
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal glomerulopathy with features of cryoglobulinemic glomerulopathy in murine multiple myeloma model.
Zhang PL; Herrera GA; Liu B
Ultrastruct Pathol; 2020 Nov; 44(4-6):387-394. PubMed ID: 33135540
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and management of monoclonal gammopathy of renal significance.
Jain A; Haynes R; Kothari J; Khera A; Soares M; Ramasamy K
Blood Adv; 2019 Aug; 3(15):2409-2423. PubMed ID: 31409583
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Gammopathy of Renal Significance Triggered by Viral E Hepatitis.
Agrawal P; Kumar V; Kumar A; Sachdeva MUS; Malhotra P; Nada R
Indian J Nephrol; 2019; 29(1):50-52. PubMed ID: 30814794
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement.
Seki JT; Sakurai N; Kukreti V
J Clin Med Res; 2015 Oct; 7(10):807-11. PubMed ID: 26346623
[TBL] [Abstract][Full Text] [Related]
18. AL Amyloidosis Complicated by Persistent Oral Bleeding.
Marconcini LA; Stewart FM; Sonntag L; Stevens E; Burwick N
Case Rep Hematol; 2015; 2015():981346. PubMed ID: 26064714
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Daily Proteinuria in Patients with Amyloidosis by Using the Protein-To-Creatinine ratio in Random Urine Samples.
Talamo G; Mir Muhammad A; Pandey MK; Zhu J; Creer MH; Malysz J
Rare Tumors; 2015 Feb; 7(1):5686. PubMed ID: 25918613
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.
Kaufman GP; Dispenzieri A; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Kapoor P; Go RS; Zeldenrust SR; Kyle RA; Rajkumar SV; Kumar SK
Am J Hematol; 2015 Mar; 90(3):181-6. PubMed ID: 25388651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
